Johnson & Johnson Prescription Unit List Prices Rose 8.5% Last Year

Johnson& Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year —and 3.5% after discounts—in the health-products company’s first effort to address criticism about the high cost of medicines by opening up about its drug-pricing practices.

Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news